直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Tobias P. Koengeter, Ph.D.
Patent Agent
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4411
tobias.koengeter@finnegan.com tobias.koengeter@finnegan.com

Tobias P. Koengeter, Ph.D.

Patent Agent

  • +1 202 408 4411 +1 202 408 4411
  • tobias.koengeter@finnegan.com tobias.koengeter@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Tobias Koengeter, Ph.D., leverages his broad scientific expertise in organic, medicinal, organometallic, and polymer chemistry to support intellectual property (IP) matters across the pharmaceutical and chemical manufacturing sectors, focusing on U.S. and international utility patent prosecution.

Tobias advises clients across a range of IP issues, primarily related to patent prosecution in the chemical and life sciences sectors. His experience includes drafting and prosecuting applications for small molecule drugs, biopharmaceuticals, automated synthesis, and chemical manufacturing. Tobias offers strategic portfolio management and supports due diligence and freedom-to-operate (FTO) analyses across diverse industries. He manages U.S. patent prosecutions and oversees global patent strategies, delivering comprehensive guidance on portfolio development.

 

Prior to joining Finnegan, Tobias conducted doctoral research at Boston College, where his activities focused on the development of new strategies for stereoselective olefin metathesis, related mechanistic analysis, and applications to the preparation of complex natural products. He also gained early exposure to IP as an intern in the university’s technology transfer and licensing office, conducting prior art searches and preparing research summaries. As an undergraduate and master’s student, he studied organometallic chromophores and the conversion of renewable feedstocks into value-added chemicals. Tobias has coauthored several peer-reviewed publications and has extensive experience as a teaching assistant at the university level.

 

Et Cetera

  • Coauthor. “Z-Trisubstituted α,β-Unsaturated Esters and Acid Fluorides through Stereocontrolled Catalytic Cross-Metathesis,” Journal of the American Chemical Society, 2023.
  • Coauthor. “Catalytic Cross-Metathesis Reactions That Afford E- and Z-Trisubstituted Alkenyl Bromides: Scope, Applications, and Mechanistic Insights,” Journal of the American Chemical Society, 2023. 
  • Coauthor. "Stereodefined alkenes with a fluoro-chloro terminus as a uniquely enabling compound class," Nature Chemistry, 2022.
  • Recipient, LaMattina Family Fellowship in Chemical Synthesis, 2021.
  • Coauthor. "Impact of Ethylene on Efficiency and Stereocontrol in Olefin Metathesis: When to Add It, When to Remove It, and When to Avoid It," Angewandte Chemie, 2020.
  • Recipient, Brian Lawrence Gray Poster Award, 2019.
  • Coauthor. "Integrated extraction and catalytic upgrading of microalgae lipids in supercritical carbon dioxide," Green Chemistry, 2019.

Professional Activities

  • American Chemical Society (ACS)
    (member)
Admissions and Education

Admissions

  • U.S. Patent and Trademark Office

Education

Georgetown University Law Center
J.D., expected 2028
Boston College
Ph.D., Chemistry, 2022
Universität Konstanz
M.Sc., Chemistry, 2017
Universität Konstanz
B.Sc., Chemistry, 2014

Languages

  • German

Tobias's Practices

Diligence, Licensing, and Opinions
Due Diligence
Freedom to Operate Opinions
Prosecution and Portfolio Management
Patent Drafting and Prosecution

Tobias's Industries

Chemicals, Industrials, and Materials
Additive Manufacturing
Chemical
Consumer Goods and Services
Food and Beverage
Energy
Clean Energy and Renewables
Oil and Gas
Life Sciences
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP